These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5395167)

  • 1. [Cerebral phospholipids in neuropsychiatry. Study of 100 cases].
    Feldmann H; Cretallaz JP
    Praxis; 1969 Nov; 58(46):1504-16. PubMed ID: 5395167
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st results of clinical trials of a phospholipid complex from bovine brain in mental syndromes].
    Baruk H; Liteanu E; Liteanu D; Cretallaz JC; Lasalle M
    Ann Med Psychol (Paris); 1967 Dec; 2(5):788-96. PubMed ID: 5626309
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the effect of a phospholipid complex from cattle brain in cerebral circulation disorders].
    Cloetens W; Cretallaz JC; Depaepe A; Bertholet G
    Med Welt; 1970 Mar; 12():510-5. PubMed ID: 5462778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with a preparation with a structural neurophospholipid base in infantile neuropsychiatry].
    Balestri L; Campanella F; Cocchi A; Invernizzi G
    Riv Sper Freniatr Med Leg Alien Ment; 1969 Feb; 93(1):192-208. PubMed ID: 5402878
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical use of phospholipids from bovine brains in patients with cerebrovascular disorders and syndromes following commotio and contusio cerebri].
    Bokonjic R
    Munch Med Wochenschr; 1973 Oct; 115(41):1807-11. PubMed ID: 4800929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of a cattle brain, phospholipid complex in cerebral ischemia syndromes].
    Cloetens W; Creatallaz JC; Depaepe A; Bertholet G
    Brux Med; 1969 Aug; 49(8):491-9. PubMed ID: 5408513
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic value of an association of phospholipids and adrenal cortex in hepatology].
    Pietranera P
    Clin Ter; 1971 Mar; 56(6):535-46. PubMed ID: 4257059
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the use in geriatrics of phospholipids and adrenal cortex extracts].
    Autore A; Fabbri C
    G Clin Med; 1970 Apr; 51(4):340-52. PubMed ID: 5273486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of the combination of hypothalamic phospholipids and megestrol acetate (IP 11) in prostatic hypertrophy. Results of a controlled clinical trial].
    Mazza G; Petracco S
    Minerva Urol; 1974; 26(6):293-300. PubMed ID: 4142804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebral phospholipids and Parkinson's disease: cross-over double-blind study versus placebo].
    Casacchia M; Meco G; Corona R; Castellana F; Cusimano G
    Riv Neurol; 1981; 51(2):101-13. PubMed ID: 7017886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experiences with the eumetric drug Rubiron].
    de Riedmatten JJ
    Praxis; 1968 Jul; 57(30):1067-9. PubMed ID: 5755493
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of brain cortex phospholipids on some enzymatic reactions of cerebral amino acid decarboxylation and possible therapeutic implications (author's transl)].
    Mazzoni S; Toffano G; Castellani A
    Riv Patol Nerv Ment; 1974 Oct; 95(5):637-50. PubMed ID: 4470263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atherosclerosis and phospholipids: considerations on pathogenesis and therapy].
    Pompei A; Traverso E; Savioli F
    Arch Maragliano Patol Clin; 1967; 23(5):511-24. PubMed ID: 5632781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological activity of lipoprotein complexes in man. (Preliminary observations on the effect of phospholipid-cytochrome C complexes on dysmetabolic-hypoxic conditions of the central nervous system)].
    Curri SB; Barberini E; Costantini FV
    Acta Neurol (Napoli); 1966; 21(6):781-97. PubMed ID: 5999481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological activity of phospholipid-cytochrome C complexes. II. Changes in the serum level of some enzymes in arteriosclerotic myocardiopathies].
    Ziliotto GR; Curri SB
    G Gerontol; 1967 Jun; 15(6):743-58. PubMed ID: 5604106
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic use of phosphatides in retinal diseases. Preliminary communication on the behaviour of visual acuity in macular disease and retinitis pigmentosa].
    Weiss H; Kosmath B
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):278-85. PubMed ID: 5555605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a poly-tissue antitoxic principle in psychiatric practice].
    Bécache A; Botta JM
    J Med Lyon; 1965 Dec; 46(89):2097-9. PubMed ID: 5852377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phospholipids in the treatment of arteriosclerotic pathological mental deterioration (PMD)].
    Bernardi S; Fanzago A
    Minerva Med; 1966 Jul; 57(54):2461-4. PubMed ID: 5946882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Brain phospholipids and cerebrovascular insufficiency].
    Manconi S; Piccardi MP; Corsini GU
    G Clin Med; 1980 Jun; 61(6):473-7. PubMed ID: 7450364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuro-homologous phospholipids in therapy].
    Meoni GC
    Clin Ter; 1969 Nov; 51(4):373-84. PubMed ID: 5404659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.